Por favor, use este identificador para citar o enlazar este ítem:http://uvadoc.uva.es/handle/10324/21811
Título
Aging Enables Ca2+ Overload and Apoptosis Induced by Amyloid- Oligomers in Rat Hippocampal Neurons: Neuroprotection by Non-Steroidal Anti-Inflammatory Drugs and R-Flurbiprofen in Aging Neurons
Año del Documento
2016
Editorial
IOS Press
Descripción
Producción Científica
Documento Fuente
J Alzheimers Dis. 2016 Jul 22;54(1):207-21
Résumé
The most important risk factor for Alzheimer’s disease (AD) is aging. Neurotoxicity in AD has been linked to
dyshomeostasis of intracellular Ca2+ induced by small aggregates of the amyloid- peptide 1-42 (A 42 oligomers). However,
how aging influences susceptibility to neurotoxicity induced by A 42 oligomers is unknown. In this study, we used longterm
cultures of rat hippocampal neurons, a model of neuronal in vitro aging, to investigate the contribution of aging to
Ca2+ dishomeostasis and neuron cell death induced by A 42 oligomers. In addition, we tested whether non-steroidal antiinflammatory
drugs (NSAIDs) and R-flurbiprofen prevent apoptosis acting on subcellular Ca2+ in aged neurons.We found that
A 42 oligomers have no effect on young hippocampal neurons cultured for 2 days in vitro (2 DIV). However, they promoted
apoptosis modestly in mature neurons (8 DIV) and these effects increased dramatically after 13 DIV, when neurons display
many hallmarks of in vivo aging. Consistently, cytosolic and mitochondrial Ca2+ responses induced by A 42 oligomers
increased dramatically with culture age. At low concentrations, NSAIDs and the enantiomer R-flurbiprofen lacking antiinflammatory
activity prevent Ca2+ overload and neuron cell death induced by A 42 oligomers in aged neurons. However, at
high concentrations R-flurbiprofen induces apoptosis. Thus, A 42 oligomers promote Ca2+ overload and neuron cell death
only in aged rat hippocampal neurons. These effects are prevented by low concentrations of NSAIDs and R-flurbiprofen
acting on mitochondrial Ca2+ overload.
Materias (normalizadas)
Alzheimer, Enfermedad de
ISSN
1387-2877
Revisión por pares
SI
Patrocinador
Ministerio de Economía y Competitividad (BFU2012- 627 37146)
Junta de Castilla y León (VA145U13, 625 BIO/VA33/13, BIO103/VA45/11)
Junta de Castilla y León (VA145U13, 625 BIO/VA33/13, BIO103/VA45/11)
Version del Editor
Idioma
eng
Derechos
openAccess
Aparece en las colecciones
Fichier(s) constituant ce document
Excepté là où spécifié autrement, la license de ce document est décrite en tant que Attribution-NonCommercial-NoDerivatives 4.0 International